Treatment Areas

Research Shows Human DNA Affects Gut Bacteria

June 30, 2020

Though the relationship between genetics and gut-dwelling bacteria is still a realm of mystery, new research has begun a new step towards better understanding how one affects the other.

FDA Approves Secukinumab for Treatment of Non-Radiographic Axial Spondyloarthritis

June 17, 2020

FDA approval for the secukinumab (Cosentyx, Novartis) for non-radiographic axial spondyloarthritis was based on results from the PREVENT trial, which showed significant reduction in disease activity.

Your New Role in the Battle Against Depression

March 15, 2017

A shortage of mental health-care providers, coupled with pharmacists’ unique skills and access to patients, has led to a significant opportunity for community and health-system pharmacists to aid in detection of depression and in medication selection and counseling for patients with depression.

Alzheimer's Disease: Untapped Potential for Pharmacy

January 18, 2017

Pharmacists can become the perfect partner in the battle against Alzheimer’s disease. Details here.

Are states going too far with painkiller script limits?

December 06, 2016

Arizona has become the latest state to limit opioid prescriptions-a trend that has some healthcare providers and experts concerned.

How Pharmacies are Helping Patients with Diabetes

November 11, 2016

When pharmacists get involved in patient care, significant improvements are often seen. Diabetes management is one of the most notable examples.

A Class of Their Own: The Unique Challenges of Type I Diabetes

November 11, 2016

While many aspects of diabetes care are universal, patients with type I diabetes (T1D) often face a unique set of obstacles and challenges.

Update on Diabetes Therapy

November 10, 2016

Despite evidence that optimal glycemic control can help reduce disease progression and complications, most patients do not achieve recommended treatment goals.

Anticoagulant therapies

October 10, 2016